How would one approach concomitant diffuse large B cell lymphoma and fibrotic phase myelofibrosis?

This is a tough case without perfect answers. I will make some assumptions to answer and say that the DLBCL likely takes priority here as it's more likely to impact patient survival in the short term. Depending on the stage/risk of both diseases that will inform how these are managed and if the DLBC...